Lei Zheng, M.D., Ph.D.

Lei Zheng, M.D., Ph.D. is Professor of Oncology and Surgery at the Johns Hopkins University School of Medicine. He is the Cancer Center and the Department of Oncology’s Assistant Director for Translational Research and Associate Cancer Center Director for Precision Medicine.  He co-leads the precision medicine research and practice at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Department of Oncology. He is Director for a new Multidisciplinary Gastrointestinal Cancer Laboratories Program at the Johns Hopkins Cancer Center.  He is also Director of the Pancreatic Cancer Precision Medicine Center of Excellence at Johns Hopkins.  His clinical work is focused on multidisciplinary management for pancreatic cancer, bile duct cancer, colorectal cancer liver metastases, and gastric cancer. He is affiliated with the Tumor Immunology Program as a laboratory investigator. His primary laboratory research focus is on the identification of new targets and strategy for pancreatic cancer immunotherapies by dissecting tumor microenvironment of pancreatic cancer.  He is considered to be one of world’s leading pancreatic cancer oncologists and researchers and one of leading experts in preclinical and clinical development of cancer immunotherapy.

He is the founding Editor-in-Chief of Annals of Pancreatic Cancer. In 2021, he was elected into the American Society of Clinical Investigation. He served or is serving as a Councilor for Pancreatic Disorders (PAN) section of the American Gastroenterological Association Institute Council, a Member of the American Society of Clinical Oncology Grant Selection Committee and Education Committee, and a Member of the American Association for Cancer Research (AACR) Program Committee. He is also chairing the China Regional Advisory Group for the AACR International Affair Committee. He is Vice Chair of the World Association of Chinese Oncologists, is currently the Secretory General of the Committee of Oversea Experts of the Chinese Society of Clinical Oncology (CSCO), and is the Immediate Past President of the Chinese American Hematologist and Oncologist Network (CAHON).  Dr. Zheng received his M.D. from Peking Union Medical College and his Ph.D. from University of Texas Health Science Center at San Antonio. He did his internal medicine training at the Long Island Jewish Medical Center (now Northwell Health and the Zucker School of Medicine at Hofstra/Northwell). He did his medical oncology fellowship training at Johns Hopkins.